Summit Therapeutics (SMMT) Earnings Date, Estimates & Call Transcripts $20.39 +0.43 (+2.15%) (As of 11/5/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Summit Therapeutics Latest Earnings SummaryUpcoming Q3 Earnings DateFeb. 18EstimatedActual EPS (Aug. 6) -$0.05 Beat By $0.01 Consensus EPS (Aug. 6) -$0.06 Summit Therapeutics issued Q2 2024 earnings on August 6, 2024, reporting an EPS of -$0.05, which topped the consensus estimate of -$0.06 by $0.01. With a trailing EPS of -$0.28, Summit Therapeutics' earnings are expected to decrease next year, from ($0.27) to ($0.29) per share. SMMT Upcoming EarningsSummit Therapeutics' next earnings date is estimated for Tuesday, February 18, 2025, based off prior year's reporting schedules. Get Summit Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Summit Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSMMT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SMMT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Summit Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ3 20241-$0.06-$0.06-$0.06Q4 20241-$0.06-$0.06-$0.0620242-$0.12-$0.12-$0.12Q1 20251-$0.06-$0.06-$0.06Q2 20251-$0.06-$0.06-$0.06Q3 20251-$0.07-$0.07-$0.07Q4 20251-$0.07-$0.07-$0.07FY 20254($0.26)($0.26)($0.26) Summit Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/18/2025(Estimated)------- 8/6/2024Q2 2024-$0.06-$0.05+$0.01-$0.01--5/1/2024Q1 2024-$0.06-$0.05+$0.01-$0.04-- 2/20/2024Q4 2023--$0.05 -$0.05-$0.05-$0.20M 11/7/2023Q3 2023--$0.03 -$0.03-$0.03-$0.27M 8/9/2023Q2 2023--$0.02 -$0.02-$0.02-- 5/11/2023Q1 2023--$0.06 -$0.06$1.31-- Get the Latest News and Ratings for SMMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Summit Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 3/9/2023Q4 2022--$0.07 -$0.07-$0.07-$1.13M 11/9/2022Q3 2022--$0.14 -$0.14-$0.14-$5.68M Summit Therapeutics Earnings - Frequently Asked Questions When is Summit Therapeutics's earnings date? Summit Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 18th, 2025 based off last year's report dates. Learn more on SMMT's earnings history. Did Summit Therapeutics beat their earnings estimates last quarter? In the previous quarter, Summit Therapeutics (NASDAQ:SMMT) reported ($0.05) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.06) by $0.01. Learn more on analysts' earnings estimate vs. SMMT's actual earnings. How much revenue does Summit Therapeutics generate each year? Summit Therapeutics (NASDAQ:SMMT) has a recorded annual revenue of $700,000.00. How much profit does Summit Therapeutics generate each year? Summit Therapeutics (NASDAQ:SMMT) has a recorded net income of -$614.93 million. SMMT has generated -$0.28 earnings per share over the last four quarters. What is Summit Therapeutics's EPS forecast for next year? Summit Therapeutics's earnings are expected to decrease from ($0.27) per share to ($0.29) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies Takeda Pharmaceutical Earnings Results BioNTech Earnings Results Moderna Earnings Results BeiGene Earnings Results Teva Pharmaceutical Industries Earnings Results Genmab A/S Earnings Results Viatris Earnings Results Dr. Reddy's Laboratories Earnings Results Sarepta Therapeutics Earnings Results Vaxcyte Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run We recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. This page (NASDAQ:SMMT) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Summit Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Summit Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.